Mouse orthotopic models for bladder cancer research.

Area of Science:

• Urology
• Oncology
• Preclinical Research

Background:

• Bladder cancer, specifically urothelial carcinoma, frequently recurs or progresses post-treatment, necessitating novel therapeutic strategies.
• Effective preclinical evaluation of new bladder cancer treatments demands reliable animal models that accurately mimic human disease.
• Current orthotopic animal models for bladder cancer exhibit variable tumor 'take' rates (30-100%), highlighting challenges in reproducibility.

Purpose of the Study:

• To review existing mouse models for orthotopic bladder cancer studies.
• To analyze implantation methods and reported tumor take rates in these models.
• To summarize recent advancements in noninvasive small animal imaging for tumor detection and quantification in preclinical research.

Main Methods:

• Review of literature on orthotopic mouse models for urothelial carcinoma.
• Analysis of implantation techniques and reported tumor take success rates.
• Summary of recent developments in noninvasive small animal imaging technologies.

Main Results:

• Various orthotopic mouse models are utilized for bladder cancer research, with inconsistent tumor take rates reported.
• Noninvasive small animal imaging techniques have significantly improved the ability to monitor tumor growth and response to treatment in vivo.
• These imaging advancements enable direct, noninvasive assessment of treatment efficacy and tumor variables.

Conclusions:

• Reliable and reproducible animal models are essential for advancing bladder cancer research and drug development.
• Noninvasive small animal imaging offers powerful tools for monitoring tumor progression and therapeutic effects in preclinical settings.
• Integrating advanced imaging with robust animal models will accelerate the discovery of novel bladder cancer therapies.